AUSTIN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Molecular Templates ... toxin bodies (ETBs), provided a corporate update and outlined expected 2022 milestones. “2021 was a year of growth ...

Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the second quarter ended June 30, 2024 and provided a regulatory and corporate update. “The FDA acceptance of ...

Milestone Systems' Christian Bohn shares an update on product releases for his firm's video surveillance management and recording solution, including their new flexibility for "client" software ...